Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06069024
What this trial is testing

Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide

Who this might be right for
Multiple MyelomaMyelodysplastic SyndromesLymphoma
Qianfoshan Hospital 38
Early research (Phase 1)Looking for participantsNCT07444268
What this trial is testing

How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood Cancers

Who this might be right for
Advanced Hematologic Malignancies
Sumitomo Pharma America, Inc. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04734990
What this trial is testing

Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic Leukemia-0Chronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+3 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00569010
What this trial is testing

Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 36
Early research (Phase 1)Ended earlyNCT04477291
What this trial is testing

CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Aptose Biosciences Inc. 45
Testing effectiveness (Phase 2)Ended earlyNCT02469415
What this trial is testing

Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 3
Early research (Phase 1)Active Not RecruitingNCT04041050
What this trial is testing

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Who this might be right for
Myeloproliferative Neoplasm
AbbVie 85
Early research (Phase 1)Active Not RecruitingNCT05233618
What this trial is testing

Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)

Who this might be right for
MyelofibrosisChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Karen Ballen, MD 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT05589896
What this trial is testing

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+8 more
Ossium Health, Inc. 12
Large-scale testing (Phase 3)Study completedNCT00450450
What this trial is testing

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+7 more
Children's Oncology Group 27
Testing effectiveness (Phase 2)Looking for participantsNCT03471260
What this trial is testing

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaHematopoietic and Lymphoid System NeoplasmMyelodysplastic Syndrome+3 more
M.D. Anderson Cancer Center 96
Testing effectiveness (Phase 2)Study completedNCT01238211
What this trial is testing

Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+5 more
National Cancer Institute (NCI) 61
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Not applicableActive Not RecruitingNCT04537871
What this trial is testing

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaHematopoietic and Lymphoid Cell Neoplasm+4 more
City of Hope Medical Center 350
Not applicableLooking for participantsNCT04645199
What this trial is testing

National Longitudinal Cohort of Hematological Diseases

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaHemophilia+14 more
Institute of Hematology & Blood Diseases Hospital, China 2,300
Early research (Phase 1)Study completedNCT00953758
What this trial is testing

PF-04449913 In Select Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Pfizer 47
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00039416
What this trial is testing

Imatinib Mesylate in Treating Patients With Myelofibrosis

Who this might be right for
Chronic Myelomonocytic LeukemiaEssential ThrombocythemiaPolycythemia Vera+1 more
National Cancer Institute (NCI) 18
Not applicableNot Yet RecruitingNCT07561385
What this trial is testing

Dresden MDS Registry With an Accompanying Biomaterial Collection

Who this might be right for
MDS (Myelodysplastic Syndrome)MDS/Myeloproliferative Neoplasm (MPN) Overlap SyndromeCHIP+1 more
Technische Universität Dresden 500
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Next Page